bmy88 ney WITH more snow and subzero temperatures on the way, households across the country are facing further condensation problems. A regular autumn and winter problem, condensation is the accumulation of water droplets that form on a window when moist air comes into contact with a cold surface. 4 Condensation is a huge problem as the colder weather sweeps in Credit: Getty 4 Tackling condensation in your loft can help your whole house Credit: Alamy 4 Loft vents help to improve ventilation 4 Loft vents cost as little as £2.20 each Not only can this make an ugly mess, but the water droplets can also lead to the growth of mould . Windows are often colder than insulated walls too, so condensation is more likely to occur on them. Poorly insulated lofts can also lead to condensation, especially when the weather dips. With snow and ice making the problem worse, thousands of people have been taking to social media to seek advice to get rid of condensation while other savvy DIY enthusiasts have shared their favourite remedies. Read more in Fabulous SEALED DEAL Home owners praise game changing buy that ‘sucks up condensation in 55 SECONDS’ AIR ME OUT My council flat had awful condensation until I made 2 simple swaps And some people have revealed that a "simple but genius device" can help eliminate condensation - and keep it at bay for good. Loft vents cost as little as £2.20 each and can help increase ventilation in your attic space which then trickles down to affect the floors below. Posting on the Screwfix forum after installing them in his home, one DIY fan said: "After a couple of weeks, I went up to the loft to check and the condensation almost completely gone. "Very impressed as the felt lap vents seemed to be doing the job and was quite easy to install." Most read in Fabulous CASH VOW Nurse cancels £30k Scots fairytale wedding after 'rose-tinted glasses come off' MUM'S THE WORD 'Relatable' Coleen Rooney praised for how she deals with sons' misbehaving HEAT UP I tried 6 kinds of Primark PJ's to see which ones are warmest according to science CHOP SHOCK Mum left sobbing as 2-year-old son cuts & SUPERGLUES her hair as she sleeps Someone else chimed in: "I have 16 fitted, eight each side and two tile vents each side, I was a bit doubtful about them at first but it helped a lot and made a big difference," A third echoed: "Lap vents made a huge difference to our condensation in the loft. The more the merrier." I was fed up waking up to soaking windows each night - I solved the issue in hours thanks to a 79p Home Bargains item - they are now bone dry A fourth wrote: "These are a great low-cost solution to what could be a very expensive problem if untreated." "These are simple but brilliant devices, cured the condensation problem", gushed a fifth. Meanwhile, a sixth added: "Easy to install and an inexpensive way to deal with loft condensation. They have been installed for about a month and seem to be doing the job." If you have the spare cash, you can even invest in a dehumidifier to absorb stubborn moisture. A winter staple for many households, a dehumidifier works ''by drawing air from the room over a coil cooled to a very low temperature by a refrigeration system'', explained the experts at the Breathing Space . The water vapour then condenses on the cold surface and the water drips into the collection bucket underneath. Although you can buy the nifty winter gadget from many retailers, including Amazon, there's no need to fork out a fortune, as portable interior dehumidifiers can be snapped up for as little as 99p in Home Bargains. The ideal humidity range for a home should be between 40% and 60%. Read more on the Scottish Sun LOOKING UP I'm a four-time world champ but my eyesight is going so I've made crucial change ISLE SAY Stunning home with panoramic views for sale for just £135k - but there's a catch Anything below this range could lead to several problems such as respiratory discomfort, dry skin, and eyes. Anything above, can cause condesation or even mould growth. What is mould and how to get rid of it? Mould is more likely to grow during the winter months. Olivia Young, Product Development Scientist at Astonish revealed exactly why this is. "Unfortunately, mould is a common problem many people face during winter. It thrives in conditions that are warm and damp, so your bathrooms are likely to be the most affected place. "That said, during the colder months most rooms in your home could be vulnerable to mould growing. "This occurs primarily from condensation that builds up on your windows when you’ve got your radiators on. "If you think about it, when windows and doors are closed, there's not much chance for the air to circulate and the moisture to make a swift exit. "This build up is what can cause dreaded mould to make an appearance, especially in bathrooms, as it creates that warm and wet environment that is a breeding ground for mould. "If left untreated, not only is it unsightly but it can also pose a serious risk to your health, so it’s really important you treat it. "The key to tackle mould is to act fast. "Try to come into as little contact with it as you can. So, grab your gloves, tie up your hair and get to work to remove any signs of mould as soon as you notice them. "To keep mould at bay, there are some simple solutions you can introduce throughout home. "The first is keep it ventilated. Yes, even in the cold winter months try to leave your bathroom window open for at least 10/15 minutes post shower or bath. This will get rid of any excess moisture quickly preventing mould gathering. "If you’re having a repeat problem with mould in one particular area, it might be because the humidity levels are too high. You can get a dehumidifier that will help keep the levels low and reduce the risk of mould returning. "The golden rule to remember when dealing with mould is the quicker you can treat it, the better. If you leave it, it will only get worse so never ignore it! "To successfully get rid of mould every time, I recommend opting for the UK's No 1 Mould & Mildew Remover , that effectively removes mould and mildew stains almost instantly, with no scrubbing necessary."Redefining Shipping in Geneva: The Journey to 2050Salesforce Inc. stock underperforms Wednesday when compared to competitors

Broncos WAGs share photos from night out in Las Vegas before Raiders game

Morning Mail: gambling syndicates buy IDs, terrorism definition up for first review since 9/11, Wallabies fall to ScotlandBill Clinton grapples with his past in memoir – too much, too little, too lateU.S. imposes new controls on chip exports to China

GLENS FALLS, N.Y. — The Adirondack Thunder can watch football all day Thursday.Before and after they’ll be busy with a three-game Thanksgiving homestand, starting Wednesday against the Trois-Rivieres Lions before battling the Reading Royals on Friday and Saturday.When it’s over, the Thunder will have played 10 games in 16 days, one of the most grueling [...]

AP Business SummaryBrief at 11:28 a.m. EST

The holiday season is upon us, and what better way to celebrate than by gifting the latest and greatest in tech toys? Whether you're shopping for a tech-savvy teen, a gadget-loving friend, or even a young aspiring engineer, there’s a world of innovative toys to spark creativity, fun, and learning. In this round-up, we’ve curated some of the best Christmas tech toys that are sure to delight and inspire... GoChess Mini Price: £199.99 An AI-powered smart chess board with colour-coded coaching lights, and online connectivity through the dedicated app. GoChess Mini isn't just about playing the game; it's about improving skills, tracking progress, and connecting with other players. Offering three play modes, users can play GoChess Mini face-to-face with an opponent or alone in AI mode (with 32 levels of difficulty to choose from). Additionally, they can connect to popular chess platforms (Lichess and Chess.com) and play against people around the world or solve challenging puzzles and revisit historical games. Maxcom Kiddo Smartwatch RRP: £69.99 The 4G Kiddo smartwatch is designed for children while also offering additional safety features, including location tracking and remote camera/microphone activation. Exciting to children and practical to parents, it's an ideal alternative to a smartphone this Christmas . The watch is packed with exciting apps, including built-in games, calculator and alarm clock. The video calling function allows them to connect with you or friends in an instant, futuristic fashion. Gel Blaster SURGE Price: £59.99 (currently £34.99) An advanced blaster with no mess or clean-up technology, meaning you can battle indoors or outdoors.. It comes with 10,000 water-based Gellets which are non-toxic, non-staining, non-irritating and pet safe. Bursting on impact, they provide safe and mess-free fun. SURGE has two blast modes - Single Shot for honing your precision and training, and Fully Automatic for dominating the competition. GoCube Price: £59.99 The iconic Rubik’s cube reimagined, the GoCube is an app-enabled speed cube that allows anyone to learn how to solve the cube. This award-winning puzzle toy and dedicated app helps users to master the cube thanks to a fun and interactive step-by-step tutorial, tracking progress in real-time. Users can play and practise with multiple mini-games to choose from or battle with friends and other cubers online to get on the global leader board. Whether learning, improving, battling or playing, GoCube takes cubing to the next level. GoBalance Play Price: £79.99 The GoBalance Play, combined with its engaging and interactive games, makes exercising fun for the entire family. This smart wobble balance board, designed by physiotherapists, enhances motor skills, core strength, flexibility, coordination and concentration. Connecting to any Android or iOS device via Bluetooth, a free app offers interactive and challenging games such as snowboarding or mini golf, that make exercising enjoyable whilst helping to develop physical and mental abilities.CHANDLER, Ariz., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, provided lower updated revenue guidance for the December 2024 quarter and announced manufacturing restructuring plans. "In the first two weeks of my newly appointed role as Interim CEO and President, I have done a deep dive into the operations of the Company and determined that certain actions are necessary. I want to clarify for investors that I plan to stay in this role, even though the title is interim, for as long as it is necessary, so there is no definitive timeline for my successor," said Steve Sanghi, Microchip's CEO, President and Chair of the Board. Mr. Sanghi continued, "We indicated in our November 2, 2024 earnings call that significant turns orders were required to achieve the midpoint of our December 2024 quarter revenue guidance. Those turns orders have been slower than anticipated and we now expect our December 2024 revenue to be close to the low end of our original guidance which is $1.025 billion." Mr. Sanghi added, "With inventory levels high and having ample capacity in place, we have decided to shut down our Tempe wafer fabrication facility that we refer to as Fab 2. Many of the process technologies that run in Fab 2 also run in our Oregon and Colorado factories, which both have ample clean room space for expansion. We expect to be able to shut down Fab 2 in the September 2025 quarter at which time we expect that it will generate annual cash savings of approximately $90 million. Due to the high inventory of the products which are manufactured in Fab 2, we do not expect to see P&L savings from the shutdown until the start of the June 2026 quarter based on a First-In First-Out basis. We expect that the Fab 2 closure will begin to help us moderate our inventory levels beginning in the March 2025 quarter. We anticipate near-term restructuring costs to be between $3 million and $8 million from these actions, and it is possible that we could incur other restructuring and shut-down costs in the future of up to an additional $15 million. The estimates of the restructuring costs will be refined over time as more information becomes available." Mr. Sanghi concluded, "I want to ensure investors of my confidence in the long-term growth and profitability of Microchip. Our design-in momentum continues to remain strong, driven by our Total System Solutions strategy and key market megatrends. The fab restructuring is a big step in right-sizing our manufacturing footprint, and we will continue to evaluate any further actions that are required to position Microchip for outsized growth and financial performance." Microchip will be participating in and presenting at the UBS Global Technology and AI Conference on December 3 and 4, 2024. Cautionary Statement: The statements in this release relating to Mr. Sanghi planning to stay in the CEO and President role for as long as it is necessary, no definitive timeline for his successor, that turns orders have been slower than anticipated and that we now expect our December 2024 revenue to be close to the low end of our original guidance which is $1.025 billion, that we have ample capacity in place, that our Oregon and Colorado factories both have ample clean room space for expansion, that we expect to be able to shut down Fab 2 in the September 2025 quarter at which time it is expected to generate annual cash savings of approximately $90 million, that we do not expect to see P&L savings from the shutdown until the start of the June 2026 quarter, that we expect that the Fab 2 closure will begin to help us moderate our inventory levels beginning in the March 2025 quarter, that we anticipate near-term restructuring costs to be between $3 million and $8 million, that is is possible that we could incur other restructuring and shut-down costs of up to an additional $15 million, ensuring investors of my confidence in the long-term growth and profitability of Microchip, that our design-in momentum continues to remain strong driven by our Total System Solutions strategy and key market megatrends, that the fab restructuring is a big step in right sizing our manufacturing footprint, that we will continue to evaluate any further actions that are required to position Microchip for outsized growth and financial performance are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause our actual results to differ materially, including, but not limited to: any continued uncertainty, fluctuations or weakness in the U.S. and world economies (including China and Europe) due to changes in interest rates, high inflation, actions taken or which may be taken by the Biden administration or the U.S. Congress or by the incoming Trump administration and the incoming U.S. Congress, monetary policy, political, geopolitical, trade or other issues in the U.S. or internationally (including the military conflicts in Ukraine-Russia and the Middle East), further changes in demand or market acceptance of our products and the products of our customers and our ability to respond to any increases or decreases in market demand or customer requests to reschedule or cancel orders; the mix of inventory we hold, our ability to satisfy any short-term orders from our inventory and our ability to effectively manage our inventory levels; the impact that the CHIPS Act will have on increasing manufacturing capacity in our industry by providing incentives for us, our competitors and foundries to build new wafer manufacturing facilities or expand existing facilities; the amount and timing of any incentives we may receive under the CHIPS Act, the impact of current and future changes in U.S. corporate tax laws (including the Inflation Reduction Act of 2022 and the Tax Cuts and Jobs Act of 2017), foreign currency effects on our business; changes in utilization of our manufacturing capacity and our ability to effectively manage our production levels to meet any increases or decreases in market demand or any customer requests to reschedule or cancel orders; the impact of inflation on our business; competitive developments including pricing pressures; the level of orders that are received and can be shipped in a quarter; our ability to realize the expected benefits of our long-term supply assurance program; changes or fluctuations in customer order patterns and seasonality; our ability to effectively manage our supply of wafers from third party wafer foundries to meet any decreases or increases in our needs and the cost of such wafers, our ability to obtain additional capacity from our suppliers to increase production to meet any future increases in market demand; our ability to successfully integrate the operations and employees, retain key employees and customers and otherwise realize the expected synergies and benefits of our acquisitions; the impact of any future significant acquisitions or strategic transactions we may make; the costs and outcome of any current or future litigation or other matters involving our acquisitions (including the acquired business, intellectual property, customers, or other issues); the costs and outcome of any current or future tax audit or investigation regarding our business or our acquired businesses; fluctuations in our stock price and trading volume which could impact the number of shares we acquire under our share repurchase program and the timing of such repurchases; disruptions in our business or the businesses of our customers or suppliers due to natural disasters (including any floods in Thailand), terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns or disruptions in the transportation system; and general economic, industry or political conditions in the United States or internationally. For a detailed discussion of these and other risk factors, please refer to Microchip's filings on Forms 10-K and 10-Q. You can obtain copies of Forms 10-K and 10-Q and other relevant documents for free at Microchip's website ( www.microchip.com ) or the SEC's website ( www.sec.gov ) or from commercial document retrieval services. Stockholders of Microchip are cautioned not to place undue reliance on our forward-looking statements, which speak only as of the date such statements are made. Microchip does not undertake any obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after this December 2, 2024 press release, or to reflect the occurrence of unanticipated events. About Microchip: Microchip Technology Incorporated is a leading provider of smart, connected and secure embedded control solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs, which reduce risk while lowering total system cost and time to market. Our solutions serve approximately 116,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com . Note: The Microchip name and logo are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies. INVESTOR RELATIONS CONTACT: J. Eric Bjornholt, Senior Vice President and CFO (480) 792-7804 © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

25 of 32 Mumbai sitting MLAs retain seats, most margins fallQuinta Brunson, Rob McElhenney Pull For Hometown Eagles In ‘Sunday Night Football’ Promo Ahead Of ‘Abbott Elementary’ & ‘It’s Always Sunny’ CrossoverDenosumab biosimilar is a monoclonal antibody commercialized by & Co, with a leading Phase III program in Post Menopausal Osteoporosis. According to Globaldata, it is involved in 2 clinical trials, which were completed. Smarter leaders trust GlobalData The gold standard of business intelligence. The revenue for Denosumab biosimilar is expected to reach an annual total of $182 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Denosumab biosimilar Overview Denosumab biosimilar (HLX-14) is under development for the treatment of giant cell tumor, bone metastases and postmenopausal women with osteoporosis at high risk for fracture. The drug candidate is a humanized monoclonal antibody. It is administered through subcutaneous route. The drug candidate acts by targeting receptor activator of nuclear factor kappa B ligand (RANKL). Organon & Co Overview & Co ( ) is a healthcare company. The company discovers and develops biosimilars and medicines. It provides medicines and solutions for various conditions including respiratory, cardiovascular, dermatology, non-opioid pain, women’s health and others. The company’s products include mometasone furoate inhalation powder, follitropin beta injection, alendronate sodium acetate injection, chorionic gonadotropin and others. distributes and sells its products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. It collaborates with pharmaceutical and biopharmaceutical businesses to market its products. It has operations in Europe North America, Asia Pacific, Latin America, Middle East, CIS and Africa. is headquartered in Jersey City, New Jersey, the US. The company reported revenues of (US Dollars) US$6,263 million for the fiscal year ended December 2023 (FY2023), an increase of 1.4% over FY2022. In FY2023, the company’s operating margin was 10.7%, compared to an operating margin of 18.2% in FY2022. In FY2023, the company recorded a net margin of 16.3%, compared to a net margin of 14.9% in FY2022. The company reported revenues of US$1,607 million for the second quarter ended June 2024, a decrease of 0.9% over the previous quarter. For a complete picture of Denosumab biosimilar’s valuation, From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. To create this model, GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, drug margins and company expenses. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company. The rNPV method integrates the probability of a drug reaching a clinical stage into the cash flow at that time, which provides a more accurate valuation, as it considers the probability that the drug never makes it through the clinical pathway to commercialization. GlobalData’s rNPV model uses proprietary likelihood of approval (LoA) and phase transition success rate (PTSR) data for the indication in the highest development stage, which can be found on GlobalData’s .

Ostin Technology Group Announces Results of Extraordinary General Meeting(The Center Square) – The Biden administration on Monday instituted a new round of restrictions targeting the export of advanced semiconductor chips and manufacturing equipment to China. This move by the Commerce Department's Bureau of Industry and Security builds on previous measures aimed at curbing China's ability to develop cutting-edge technologies, particularly artificial intelligence and military applications. The new export controls place 140 manufacturers and investment companies on the Entity List, a U.S. compilation of "foreign individuals, companies, and organizations deemed a national security concern." "The United States has taken significant steps to protect our technology from being used by our adversaries in ways that threaten our national security," National Security Advisor Jake Sullivan said in a statement . The new controls will also block the sale of high-bandwidth memory, which is necessary for artificial intelligence. Semiconductors can be a strategic asset for AI systems, supercomputing, and other technologies for both civilian and military use. Sullivan continued, "As technology evolves, and our adversaries seek new ways to evade restrictions, we will continue to work with our allies and partners to proactively and aggressively safeguard our world-leading technologies and know-how so they aren't used to undermine our national security." According to a U.S. Government Accountability Office report, semiconductors, also known as computer chips, are typically smaller than a postage stamp and are composed of billions of components that can store, move and process data. Advanced semiconductors can be used for artificial intelligence, including in medical diagnosis and for military purposes, such as modeling nuclear explosions. The U.S. has been tightening down on the export controls on semiconductors to China since concerns over U.S. capacity to produce advanced semiconductors domestically when shortages began during the pandemic. This concern resulted in Congress enacting the CHIPS Act of 2022. Chinese foreign ministry spokesperson Lin Jian responded. "This type of behavior seriously violates the laws of market economy and the principle of fair competition, disrupts international economic and trade order, destabilizes global industrial and supply chains, and will eventually harm the interests of all countries," Jian said. Beijing intends to take firm, resolute measures to defend the interests of Chinese companies, he added. Assistant Secretary of Commerce for Export Administration Thea D. Rozman Kendler said, "The PRC's Military-Civil Fusion strategy presents a significant risk that advanced node semiconductors will be used in military applications that threaten the security of the United States, as well as the security of our allies and partners."

Risk adjusted net present value: What is the current valuation of Bristol-Myers Squibb’s Arlocabtagene autoleucel?Saquon Barkley is the NFL's version of Shohei Ohtani: Analysis

NAPLES, Fla. (AP) — Down by two shots with two holes to play, Jeeno Thitikul knew exactly what was needed to capture the biggest prize in women's golf history. And another eagle-birdie finish — for the second straight day — made it happen. Thitikul claimed the record-setting $4 million first-place check by winning the CME Group Tour Championship on Sunday. It's the biggest money prize in women’s golf history, bigger than even the winner’s shares in three of the four men’s major championships this year. “Today, standing here with the trophy, it's more than I can ask for,” Thitikul said. Thitikul shot a 7-under 65 on Sunday and finished the week at 22 under, one shot ahead of Angel Yin (66). Yin had a two-shot lead walking to the 17th tee, only to wind up settling for the $1 million runner-up check. Yin — who missed the start of the season after breaking her leg over the winter — hardly sounded defeated after finishing second and more than doubling her 2024 earnings in four days. “I’m pretty awesome. ... I’ve learned that I just need to believe my myself and that’s what I did," Yin said. Brooke Henderson (66) of Smiths Falls, Ont., tied for eighth at 13-under overall. The win and the massive check came down to the 18th hole, Thitikul and Yin tied at 21 under after a back-and-forth day atop the leaderboard — both knowing a mistake would likely come at a $3 million cost. Both hit the fairway on 18. Thitikul’s approach was nearly perfect, stopping about 5 feet from the cup. Yin’s response stopped maybe 15 feet away, giving Thitikul the edge as they walked up the fairway. She was smiling broadly as she approached the green, almost as if she knew what was about to happen. Yin’s birdie putt just missed. Thitikul’s was dead center. And history was hers. Her plans for all that cash? “Definitely spend it,” Thitikul said. “That’s an honest answer, for sure. Definitely going to spend it for a little while.” She already had clinched a $1 million bonus this week through the Aon Risk-Reward Challenge, a competition based on how players score on a designated hole each week. In the end, it wound up as a whopping $5 million week for the 21-year-old from Thailand — and going 8 under on the Nos. 17 and 18 over the four days at Tiburon Golf Club made the difference. “All the hard work paid off,” said Thitikul, whose eagle-birdie close to Saturday's round pulled her into a tie for the lead with Yin going into Sunday at 15 under. It didn’t take long on Sunday for Thitikul to jump in front, with birdies on two of the first three holes to grab a two-shot edge. Her lead vanished with a two-shot swing on the par-4 fourth; Yin made birdie, Thitikul bogey. It seemed like Yin grabbed control on the par-3 16th. Her birdie putt from across the green — about 25 feet — rolled in for a two-shot lead with two holes to play. But her second shot at the par-5 17th missed the green right, and the door was opened for Thitikul. The eagle-birdie finish Saturday gave her hope. The eagle-birdie finish Sunday gave her so much more — even though, it turns out, the second shot on the par 5 wasn't one that she caught flush. It worked out anyway. “Just lucky enough,” Thitikul said. Olympic gold medalist Lydia Ko (63) finished third at 17 under, her nine birdies coming in a 13-hole span. “I’m excited to be able to work hard this offseason and have another great 2025,” Ko said. Ruoning Yin (68) was alone in fourth at 16 under, and LPGA player of the year Nelly Korda (66) finished at 15 under along with Narin An (68). Ayaka Furue finished at 13 under, good enough to give her the Vare Trophy as the LPGA’s season-long scoring champion over Haeran Ryu. “I feel very happy to have this trophy in my hands,” said Furue, the first Japanese player to win the Vare. Lexi Thompson — a 15-time winner as a pro who plans to step away from full-time golf — finished at 2 under. It’s not clear how often Thompson plans to play in 2025 and beyond; that said, she returns to Tiburon the week of Dec. 9 for the Grant Thornton Invitational, where she’ll team with Rickie Fowler in the event featuring PGA Tour and LPGA Tour players. “I’m not going anywhere, guys.” Thompson said. “I’ll be back in two weeks.” There were two players who said they were retiring after Sunday’s round: Marina Alex, who shot 66 to finish at 12 under, and Ally Ewing, who closed with a 68 to wrap up the week at 11 under. “I’m happy to have ended on my best,” said Alex, a bottle of sparkling wine in her right hand, a bouquet of flowers in the other. Added Ewing: “I’ve been at peace with my decision. It’s just so nice to be able to share the walk with my family this week.” But in the end, the week belonged to Thitikul. And as the sun was setting over Tiburon on Sunday, she was ready for her offseason to begin with a well-deserved celebration. “Anybody hungry?” she asked. “I am.” With Sunday's check in her pocket, she can dine anywhere she wants for a while. ___ AP golf: https://apnews.com/hub/golf Tim Reynolds, The Associated Press

By Muhammad Salihu Ahmad The livestock sector in Nigeria has immense potential to drive economic growth, enhance food security and alleviate poverty. However, despite being a significant contributor to the country’s agricultural GDP, the sector has long suffered from underperformance due to systemic challenges of weak policy implementation due to bureaucratic inefficiencies and lack of political will. Past livestock sector reform efforts were hindered by inconsistent policies and weak institutional frameworks. While there are various government initiatives aimed at boosting livestock production, these efforts are often fragmented and poorly coordinated. Policies frequently change with successive administrations, disrupting long-term planning and investment. Additionally, the lack of a cohesive national livestock development plan leads to duplications and inefficiencies. The establishment of a dedicated Ministry of Livestock Development signals a focused effort to address the challenges facing the sector. However, specific issues related to pastoralists—who play a central role in Nigeria’s livestock industry—pose significant hurdles to the success of such initiatives. Pastoralists primarily rely on open grazing systems, which require extensive land for their livestock. The increasing pressure on land due to urbanisation, agricultural expansion, and population growth has led to the encroachment of traditional grazing routes and reserves. This indicates that the traditional pastoral systems, where herders moved their cattle across regions in search of grazing land, are increasingly unsustainable as farmland expands and climate change reduces available pasture. Climate change has aggravated desertification and reduced the availability of grazing resources, pushing pastoralists to migrate southward in search of pastures. This migration often leads to clashes with farming communities and heightens regional tensions. Reform must therefore account for the environmental challenges pastoralists face, or it will fail to address the underlying vulnerabilities. The long-standing conflicts between pastoralists and crop farmers that intensified in recent years, have resulted in violence, loss of lives, and displacement. The degeneration of these conflicts has resulted in insecurity where the pastoralists are both victims and, at times, accused perpetrators of insecurity, including cattle rustling and banditry. Without addressing the root causes of these conflicts—such as competition for land and water resources, weak conflict resolution mechanisms, and ethnic tensions—any reform initiative will only struggle to gain acceptance or foster peaceful coexistence. The inability of law enforcement agencies to curb these threats undermines investor confidence and discourages private sector participation in the livestock industry. Governance issues, such as the lack of accountability and transparency in resource allocation, further hinder efforts to address the sector’s challenges effectively. The reform needs to address the security needs of pastoralists to foster their cooperation, as pastoralism is deeply rooted in the cultural and traditional practices of many communities, particularly among the Fulani. To them, policies aimed at transitioning to modern livestock management systems, such as ranching, may be perceived as undermining their heritage. Cognisance should, therefore, be taken of social and cultural factors so as not to impede the livestock sector reform. Gender dynamics within the sector may also present a challenge, as women, who play a crucial role in small-scale livestock farming, often lack access to resources and decision-making opportunities. Addressing these social and cultural barriers will be essential for achieving inclusive and sustainable reforms. Efforts should be made by the new Ministry to adopt the participatory approach towards evolving innovative interventions. The livestock farmer is also contending with climate and environmental challenges. Rising temperatures, erratic rainfall patterns and desertification have reduced the availability of pasture and water. Prolonged droughts and shrinking water bodies are forcing pastoralists to migrate southward, increasing tensions with farming communities. Moreover, climate change worsens the spread of diseases that significantly reduce livestock productivity. The environmental impact of livestock farming, including overgrazing and deforestation, further compounds these challenges, making sustainable reform even more critical. A significant hurdle to the livestock sector reform is inadequate infrastructure. The lack of modern slaughterhouses, cold storage facilities, and transportation networks is impeding the efficient processing and distribution of livestock products. Most livestock farmers, especially in rural areas, operate in informal and underdeveloped markets, leading to significant post-harvest losses that reduce profitability and market competitiveness. These are compounded by the industry’s limited access to finance and technology. Most livestock farmers in Nigeria operate at a subsistence level, with limited access to credit and modern technology. The lack of affordable financing options restricts farmers’ ability to invest in improved breeds, quality feed, veterinary care and value addition. Furthermore, low literacy level among rural farmers has hindered their ability to adopt modern livestock management practices and technologies. The gap between research institutions and local farmers has limited the dissemination of innovations that could enhance productivity and has also remained minimal due to high costs and limited technical expertise. But worse, Nigeria’s livestock sector is suffering from insufficient investment in research and development (R&D). Many research institutions lack the funding and infrastructure needed to conduct studies on feed production, breed improvement and disease management. Consequently, the sector relies heavily on outdated practices and technologies. At the other end of the scale the livestock value chain in Nigeria is highly fragmented, with weak linkages between producers, processors, and marketers. This fragmentation limits economies of scale and reduces the competitiveness of Nigerian livestock products in both local and international markets. Informal market structures dominate the sector, characterised by poor hygiene standards and low-quality products. Furthermore, the lack of export-oriented policies and certification systems restricts Nigeria’s ability to tap into lucrative global markets for meat, dairy, poultry and leather products. With care, the livestock sector in Nigeria has the potential to be a cornerstone of the nation’s agricultural transformation. However, achieving sustainable reform requires addressing the multifaceted challenges that hinder its growth through a holistic and multi-stakeholder approach in policy harmonisation, infrastructural development, stronger livestock extension services, implementation of climate-smart livestock production practices, increased funding in research and development, credit schemes with ease of access to finance, conflict resolution and promotion of dialogue with collaboration between farmers and herders, and market integration to strengthen value chains and increase competitiveness. Ahmad wrote from FMA2 off Yaya (Petal) Abubakar Road, Fadamar Mada, Bauchi [email protected] Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.Percentages: FG .569, FT .607. 3-Point Goals: 9-18, .500 (Thomas 2-2, Watkins 2-3, Deng 2-4, Holt 1-1, Swinton 1-1, Davis 1-2, Bol Bowen 0-1, Crawford 0-1, Rozakeas 0-1, Jackson 0-2). Team Rebounds: 6. Team Turnovers: None. Blocked Shots: 4 (Bol Bowen, Deng, Ewin, Holt). Turnovers: 11 (Jones 2, Bol Bowen, Davis, Deng, Ewin, Maluk, Mbatch, Swinton, Thomas, Watkins). Steals: 7 (Bol Bowen 2, Crawford, Davis, Jackson, Maluk, Swinton). Technical Fouls: Bol Bowen, 14:54 second. Percentages: FG .310, FT .690. 3-Point Goals: 3-24, .125 (Curry 1-2, Rivera 1-4, Guerengomba 1-6, Ndjigue 0-1, Watson 0-1, Worthy 0-2, Diggins 0-8). Team Rebounds: 8. Team Turnovers: 1. Blocked Shots: 1 (Rivera). Turnovers: 16 (Rivera 3, Worthy 3, Curry 2, Hankins-Sanford 2, Abdelgowad, Diggins, Guerengomba, Muhammad, Ndjigue, Watson). Steals: 7 (Ndjigue 3, Rivera 2, Abdelgowad, Diggins). Technical Fouls: None. .

Florida State made official on Monday the hiring of Gus Malzahn as offensive coordinator, confirming weekend reports that he would resign as UCF head coach to reunite with Seminoles coach Mike Norvell. UCF had confirmed on Sunday reports of Malzahn's exit but not his destination, and FSU had not made an announcement until Monday afternoon. "I am excited to be here at Florida State and to help us win championships," Malzahn said in a statement. "It's exciting to work with Coach Norvell, who is someone I believe in as a coach and leader." Norvell, who served as a graduate assistant under Malzahn at Tulsa in 2007-08, said on Saturday night after the Seminoles' 31-11 loss to Florida that he could not identify the new offensive coordinator until the hiring process was finalized. Florida State, which is 2-10 overall and 1-7 in the Atlantic Coast Conference, is ranked No. 132 of 133 FBS programs in total offense (270.2 yards per game). The Seminoles are 130th in the nation in scoring offense (15.4 points per game). Norvell shook up his staff, including firing offensive coordinator/offensive line coach Alex Atkins on Nov. 10 after a 52-3 defeat at Notre Dame. "I'm extremely excited to have Gus Malzahn join our staff at Florida State," Norvell said in the school's statement on Monday. "He has one of the most innovative minds in college football and a proven track record of developing elite offenses everywhere he's been. "His offenses have consistently showcased a tremendous running game combined with explosive plays through the air. I'm thrilled to work side-by-side with Gus again as we elevate the Florida State offense back to one of the elite groups in college football." UCF also endured a tough 2024 season, going 4-8 after losing eight of its last nine games. During Malzahn's four-year tenure, the Knights went 28-24, including 5-13 in the Big 12 Conference the last two seasons. Malzahn, 59, is 105-62 in 13 seasons as a college head coach, highlighted by a 68-35 mark in eight seasons at Auburn -- which included a BCS title game appearance in 2013. He served as offensive coordinator and play caller when the Tigers won the national title in 2010. Malzahn will be tasked with revitalizing a Florida State offense that helped produce a 13-1 campaign in 2023, when the Seminoles were denied a spot in the College Football Playoff. Over the last three seasons at UCF, his rushing attack has been in the Top 10 in the nation. In his 19 seasons as a college head coach or offensive coordinator, Malzahn's teams have averaged 447.7 yards per game, and three of his teams eclipsed 7,000 yards in a season. --Field Level MediaStock market today: Losses for Big Tech pull US indexes lower

ASML Deadline: ASML Investors with Losses in Excess of $100K Have Opportunity to Lead ASML Holding N.V. Securities Fraud Lawsuit"For the sake of argument, let's assume you will live 100 years. Many more people make it there considering all of the technological and medical advances. Now, we will break 100 years into the four seasons — spring, summer, fall and winter..." "The first 25 years are like the spring season. Everything is young and tender, like the little buds that sprout on the trees. The first flowers bloom. Many animals give birth in spring. Most of your book learning will end, and experiential learning will begin. Human summertime lasts from 26 to 50. These are mature (but still very youthful) years. Trees come into full foliage, and little birds leave their nests. Most important life decisions should be finalized in the human summer. Fall will come at you fast. The years 51 to 75 are human autumn. Hairs fall just like leaves on the trees. Hopefully, you will reach your peak earning years and settle into retirement by the end of the fall (if you've made the right financial decisions). This is normally when autumners may welcome grandchildren! A stark reminder of how it felt to live in spring. When winter shows up, you'll be between 76 and 100. If you've taken care of your health, you may still get around fairly well. But there will be no denying that things are much harder than they used to be. Hair begins to look like a Some great-grandchildren may even show up! Well, we're at the end of our seasons. That 33-year-old you were asking about isn't even halfway through summer! Just a pup, really. I hope this was worth the time I spent and that I've answered your question." — Memaw , Quora user And, finally, here is this person's breakdown of age: "35 is still young, though not 'young young.' Maybe you could call it the 'middle-aged young.' A strictly personal breakdown: 20s — the young young 30s — the middle-aged young 40s — the old young -> [second half] transition to middle age 50s — the middle-aged 60s — the old middle-aged and transition to old age 70s — the young old 80s — the middle-aged old and transition to old old 90s — the old old To me, the high points have been 40 and 70. Stay in shape, and you have a lot to look forward to." — Annie Gottlieb , Quora user So, now we open the floor to you. What age is considered "old" in your mind and what are your thoughts about aging in general? Let us know in the comments! Some submissions have been edited for length and/or clarity.

LY-3541860 is a monoclonal antibody commercialized by Co, with a leading Phase II program in Relapsing Multiple Sclerosis (RMS). According to Globaldata, it is involved in 3 clinical trials, of which 1 was completed, and 2 are ongoing. Smarter leaders trust GlobalData The gold standard of business intelligence. The revenue for LY-3541860 is expected to reach an annual total of $19 mn by 2040 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. LY-3541860 Overview Eli Lilly and Co Overview Co (Lilly) is a healthcare company that discovers, develops, and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, autoimmune disorders, men’s health, and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. Lilly conducts research and development activities to discover and deliver innovative medicines. It promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company operates R&D facilities, and production and distribution facilities in North America, South America, Europe, the Middle East, Africa and Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US. The company reported revenues of (US Dollars) US$34,124.1 million for the fiscal year ended December 2023 (FY2023), an increase of 19.6% over FY2022. In FY2023, the company’s operating margin was 18.9%, compared to an operating margin of 25% in FY2022. In FY2023, the company recorded a net margin of 15.4%, compared to a net margin of 21.9% in FY2022. The company reported revenues of US$11,302.8 million for the second quarter ended June 2024, an increase of 28.9% over the previous quarter. For a complete picture of LY-3541860’s valuation, From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. To create this model, GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, drug margins and company expenses. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company. The rNPV method integrates the probability of a drug reaching a clinical stage into the cash flow at that time, which provides a more accurate valuation, as it considers the probability that the drug never makes it through the clinical pathway to commercialization. GlobalData’s rNPV model uses proprietary likelihood of approval (LoA) and phase transition success rate (PTSR) data for the indication in the highest development stage, which can be found on GlobalData’s .34 Lives Rescues 34 Kidneys

How to buy Florida Gators vs. Florida State Seminoles tickets